
SyndicateRoom
Description
SyndicateRoom, headquartered in Cambridge, United Kingdom, operates as a venture capital platform primarily through its Access EIS fund. This fund distinguishes itself by co-investing alongside some of the UK's most successful angel investors, aiming to build highly diversified portfolios of early-stage startups. The core philosophy revolves around mitigating risk by spreading investments across a large number of companies and leveraging the due diligence and expertise of experienced angel investors who lead the rounds. This model allows SyndicateRoom to gain exposure to promising UK tech and growth companies identified and vetted by seasoned professionals.
The Access EIS fund specifically targets early-stage companies within the UK, focusing on sectors that demonstrate high growth potential. Its strategy is to back companies that have already secured investment from a top-performing angel, ensuring a level of initial validation. The fund's objective is to construct a robust portfolio of 50 or more startups, reflecting a strong commitment to diversification as a primary risk management tool. This approach provides investors with exposure to a broad range of emerging businesses without the need for individual deal selection.
As of 2021, the Access EIS fund had deployed over £20 million across more than 60 companies, indicating an average investment of approximately £333,000 per company. While the fund has the capacity to invest up to £5 million into a single company over its lifetime, its typical initial cheque sizes are considerably smaller to facilitate the broad diversification strategy. SyndicateRoom's unique co-investment model positions it as a significant player in the UK's early-stage funding ecosystem, providing capital to promising ventures while offering a structured, diversified investment vehicle for its own limited partners.
Investor Profile
SyndicateRoom has backed more than 124 startups, with 3 new investments in the last 12 months alone. The firm has led 11 rounds, about 9% of its total and boasts 6 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Equity Crowdfunding, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, India.
- Strong thematic focus on Health Care, Software, Medical.
- Typical check size: $100K – $1M.
Stage Focus
- Seed (46%)
- Equity Crowdfunding (23%)
- Series Unknown (11%)
- Pre Seed (9%)
- Angel (6%)
- Series A (2%)
- Series B (2%)
Country Focus
- United Kingdom (94%)
- United States (5%)
- India (1%)
Industry Focus
- Health Care
- Software
- Medical
- Biotechnology
- Information Technology
- Medical Device
- E-commerce
- Financial Services
- Artificial Intelligence (Ai)
- Fintech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.